ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Pre Transplant Intact FGF 23 Modifies Post-Transplant Improvement in Cognition

J. A. Klein1, A. Jurgensen1, J. Stubbs1, P. Rowe1, D. Cibrik1, W. Brooks2, J. Burns3, Z. Lauer4, A. Gupta1

1Nephrology, University of Kansas Medical Center, Kansas City, KS, 2KU Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, 3Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, 4Internal Medicine, University of Kansas Medical Center, Kansas City, KS

Meeting: 2019 American Transplant Congress

Abstract number: C122

Keywords: Kidney transplantation, Monitoring

Session Information

Date: Monday, June 3, 2019

Session Name: Poster Session C: Kidney Psychosocial

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Cognition and Self-Management in Liver Transplant Recipients
  • Global and Domain Specific Cognition in Liver Transplant Recipients

*Purpose: Fibroblast growth factor 23 (FGF23) has been associated with cognitive impairment in ESRD. Both FGF23 levels and cognition improve post-kidney transplantation (KT). It is unknown whether pre-KT FGF23 levels modify improvement in cognition.

*Methods: We assessed various domains of cognition pre-KT and 12 weeks post-KT with a battery of standard neuropsychological (NP) tests. We measured intact serum FGF23 (iFGF23) levels pre-and post-KT via ELISA CY-4000 (KAINOS Laboratories, Tokyo, Japan). We examined the correlation between pre-transplant iFGF23 levels and change in NP test performance pre to post-KT.

*Results: Twenty patients underwent iFGF23 and cognitive testing before and 12 weeks post-KT. Mean age was 49.8±11.6 years. Of the twenty, 12 were men and 19 were white. Mean iFGF23 prior to KT was 9060.8 (pg/ml) and 12 weeks post was 76.53 pg/ml (p = 0.004). Compared to pre-KT, Logical memory, Trailmaking B, Digit Symbol and Delayed Logical Memory all showed a statistically significant improvement post-KT.

Neuropsychiatric Testing Pre and Post KT
Time MMSE (0-30) Logical Memory (0-25) Trail A (<150 s) Trail B (<300 s) Mean Trail (s) Digit Symbol (0-93) Delayed Logical Memory (0-25)
Pre-KT 28.4 11.65 24.1 80.7 55.7 47.7 10.6
12 wk post-KT 28.7 14.85* 26.3 66.9** 50.3 50.7* 15.7*

p<0.05* p<0.10**

Correlation coefficient for pre-KT iFGF23 versus change in cognitive testing was (r=0.02, p=0.94) for MMSE, (r=0.05, p=0.82) for Logical Memory, (r=-0.27, (p=0.24) for Trailmaking A, (r=-0.15, p=0.52) for Digit Symbol, and (r=0.20, p=0.39) for Delayed Logical Memory. In contrast to these results, the correlation coefficients for Trailmaking B (r=-0.51, p=0.02) and Mean Trailmaking (r=0.48, p=0.03) revealed statistical significance.

*Conclusions: Intact FGF23 normalizes after successful KT. Compared to pre-KT, Logical memory, Trailmaking B, Digit Symbol and Delayed Logical Memory all showed significant improvement post-KT. Furthermore, high pre-KT iFGF23 level is associated with lack of improvement in cognition post-KT as demonstrated by Trailmaking B assessment. Trailmaking B shows potential as a specific NP domain that details predictive changes in executive function post-KT. Based upon our findings, further prospective studies are needed to validate these results.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Klein JA, Jurgensen A, Stubbs J, Rowe P, Cibrik D, Brooks W, Burns J, Lauer Z, Gupta A. Pre Transplant Intact FGF 23 Modifies Post-Transplant Improvement in Cognition [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/pre-transplant-intact-fgf-23-modifies-post-transplant-improvement-in-cognition/. Accessed February 27, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.